Open access
Aug 2026
PACM-01 RECEPTOR-COMPLEX–SPECIFIC CD200 ACTIVATION RECEPTOR TARGETING DRIVES COMPARTMENT-SPECIFIC ANTI-TUMOR IMMUNITY IN BREAST CARCINOMA
Abstract Despite advances in systemic therapy for primary breast carcinoma (BC), up to 30% of patients with advanced disease will develop central nervous system (CNS) metastases. Intracranial progression remains largely incurable and is associated with substantial morbidity. The median survival following diagnosis of b...
S. Frederico, R. Bose, Lindsey Sloan et al.
· Neuro-Oncology Advances · 0 citations